These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34060065)

  • 1. Evaluation of the pharmacokinetics of prednisolone in paediatric patients with acute lymphoblastic leukaemia treated according to Dutch Childhood Oncology Group protocols and its relation to treatment response.
    Sassen SDT; Mathôt RAA; Pieters R; de Haas V; Kaspers GJL; van den Bos C; Tissing WJE; Te Loo DMWW; Bierings MB; van der Sluis IM; Zwaan CM
    Br J Haematol; 2021 Jul; 194(2):423-432. PubMed ID: 34060065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.
    Kaspers GJ; Pieters R; Van Zantwijk CH; Van Wering ER; Van Der Does-Van Den Berg A; Veerman AJ
    Blood; 1998 Jul; 92(1):259-66. PubMed ID: 9639525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia.
    Wallace AM; Tucker P; Williams DM; Hughes IA; Ahmed SF
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):770-6. PubMed ID: 12780755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
    Veerman AJ; Kamps WA; van den Berg H; van den Berg E; Bökkerink JP; Bruin MC; van den Heuvel-Eibrink MM; Korbijn CM; Korthof ET; van der Pal K; Stijnen T; van Weel Sipman MH; van Weerden JF; van Wering ER; van der Does-van den Berg A;
    Lancet Oncol; 2009 Oct; 10(10):957-66. PubMed ID: 19747876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of prednisolone in children with acute lymphoblastic leukaemia.
    Choonara I; Wheeldon J; Rayner P; Blackburn M; Lewis I
    Cancer Chemother Pharmacol; 1989; 23(6):392-4. PubMed ID: 2713960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
    Mitchell CD; Richards SM; Kinsey SE; Lilleyman J; Vora A; Eden TO;
    Br J Haematol; 2005 Jun; 129(6):734-45. PubMed ID: 15952999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dexamethasone on quality of life in children with acute lymphoblastic leukaemia: a prospective observational study.
    de Vries MA; van Litsenburg RR; Huisman J; Grootenhuis MA; Versluys AB; Kaspers GJ; Gemke RJ
    Health Qual Life Outcomes; 2008 Nov; 6():103. PubMed ID: 19036151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro resistance of leukaemic blasts to prednisolone in bcr-abl positive childhood acute lymphoblastic leukaemia.
    Gupta M; Kumar A; Dabadghao S
    Indian J Med Res; 2002 Dec; 116():268-72. PubMed ID: 12807155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia.
    Pottier N; Yang W; Assem M; Panetta JC; Pei D; Paugh SW; Cheng C; Den Boer ML; Relling MV; Pieters R; Evans WE; Cheok MH
    J Natl Cancer Inst; 2008 Dec; 100(24):1792-803. PubMed ID: 19066270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated intraocular pressure in children with acute lymphoblastic leukaemia: A prospective study.
    Barzilai-Birenboim S; Elitzur S; Nirel R; Ehrenberg M; Zahavi A; Avrahami G; Gabbay IE; Gilad G; Dotan G; Izraeli S; Daood RH; Geffen N
    Br J Haematol; 2022 Mar; 196(5):1248-1256. PubMed ID: 34862597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients.
    Sassen SD; Mathôt RA; Pieters R; Kloos RQ; de Haas V; Kaspers GJ; van den Bos C; Tissing WJ; Te Loo M; Bierings MB; Kollen WJ; Zwaan CM; van der Sluis IM
    Haematologica; 2017 Mar; 102(3):552-561. PubMed ID: 28250007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study.
    Balis FM; Holcenberg JS; Poplack DG; Ge J; Sather HN; Murphy RF; Ames MM; Waskerwitz MJ; Tubergen DG; Zimm S; Gilchrist GS; Bleyer WA
    Blood; 1998 Nov; 92(10):3569-77. PubMed ID: 9808549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
    Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE
    J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
    van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to glucocorticoids in childhood acute lymphoblastic leukemia: impact of relationship between ex vivo sensitivity and in vivo concentration on risk factor analysis.
    Styczynski J; Koltan A; Wysocki M
    Neoplasma; 2006; 53(2):168-73. PubMed ID: 16575474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
    Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate pharmacokinetics in childhood acute lymphoblastic leukaemia: a prognostic value?
    Martelli N; Mathieu O; Margueritte G; Bozonnat MC; Daurès JP; Bressolle F; Hillaire-Buys D; Peyrière H
    J Clin Pharm Ther; 2011 Apr; 36(2):237-45. PubMed ID: 21366654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.